You are here: Industry Insights > COPD

News List

COPD May Strike Women Harder Than Men drugs
May 23, 2019
Women with chronic obstructive pulmonary disease (COPD) appear to have a harder time than men with the progressive lung disorder, a new study suggests.
Women With COPD Have Worse QoL, Increased Symptom Burden drugs
May 23, 2019
Women With COPD Have Worse QoL, Increased Symptom Burden.
More than 40 percent of women with asthma may develop COPD europeanpharmaceuticalreview
April 22, 2019
“Previous studies have found an alarming rise in ACOS in women in recent years and that the mortality rate from ACOS was higher in women,” said Prof To…
Spry Health announces FDA Clearance of Groundbreaking Loop System for COPD biospectrumasia
April 14, 2019
Technology Aims to Reduce Hospital Admissions, Provide Peace of Mind to Patients and Caregivers
Another EU patent for Verona in COPD drug pharmatimes
April 10, 2019
The European Patent Office has granted Verona pharma an additional key patent for its chronic obstructive pulmonary disease (COPD) drug, ensifentrine (RPL554)...
Generic Advair will put the squeeze on GSK this year pharmaphorum
February 14, 2019
GlaxoSmithKline has confirmed it will face a challenging 2019 as generics of its big-selling Advair drug finally reach the US, as it continues the transformation of its business....
Pharma companies clear the R&D decks in Q4 pharmaphorum
February 13, 2019
The fourth-quarter results season has already seen a host of unwanted projects cleared from pharma companies’ pipelines as they tighten their focus on the projects with the most chance of a good return on investment.
Mylan's generic version of ADVAIR DISKUS for asthma, COPD patients gets FDA approval biospectrumasia
February 02, 2019
The European Medicine Agency has launched a six month consultation on the principles that will form the basis of the electronic product information (ePI)…
FDA approves first generic Advair Diskus worldpharmanews
February 01, 2019
The U.S. Food and Drug Administration approved the first generic of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) for the twice-daily treatment of asthma in...
Propeller Health announces My Pharmacy, enabling in-app pharmacy experience for patients with asthma and COPD firstwordpharm
January 10, 2019
Propeller Health, a leading digital therapeutics company, today announced My Pharmacy, connecting Propeller users living with asthma and chronic obstructive pulmonary disease (COPD) directly to pharmacy services in the Propeller mobile app.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page